Vitrue Health
PrivateLast Round
Series A
Feb 29, 2024
Total Funding Raised
$6.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vitrue Health operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series A round in February 2024.
Vitrue Health is a health technology company that provides a digital platform using AI and computer vision to assess, prevent, and treat musculoskeletal conditions for workplaces.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Computer Vision, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vitrue Health Comparables
Compare Vitrue Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exer AI | 86% | |
| Kinetisense | 83% | |
| Kemtai | 83% |
For institutional investors. Book with your work email.
Vitrue Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 29, 2024 | ||||
| Seed | Dec 5, 2021 | ||||
| Accelerator | Jul 30, 2019 | ||||
| Grant | Mar 8, 2019 | ||||
| Grant | Dec 17, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vitrue Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Simplyhealth Ventures | Series A |
| Salica Investments | Series A, Seed |
| Techstars | Accelerator |
| Howard Ventures | Seed |
| Innovate UK | Grant |
| Crista Galli Ventures | Series A, Seed |
| MMC Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 33, 9.4x the trailing average.
- Feb 29, 2024
$4M round led by Hambro Perks Ltd., MMC Ventures, and Salica Investments.
For institutional investors. Book with your work email.
Vitrue Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vitrue Health's valuation, stock price, and market status.
Is Vitrue Health a public or private company?
Vitrue Health is a private company.
What is the current stock price of Vitrue Health?
Vitrue Health is a private company, so its shares have no public market price. Caplight tracks Vitrue Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vitrue Health worth (valuation)?
Valuation information for Vitrue Health is not publicly available.
Can I buy Vitrue Health stock?
Vitrue Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vitrue Health's last funding round?
Vitrue Health's most recent funding round was Series A on February 29, 2024.
Who are the main investors in Vitrue Health?
Key investors in Vitrue Health include Salica Investments, Techstars, Innovate UK, MMC Ventures, Hambro Perks Ltd..
Will Vitrue Health IPO soon?
No public IPO plans have been announced for Vitrue Health.
How can I track Vitrue Health secondary market activity?
Caplight tracks bids, offers, and trades in Vitrue Health's shares on secondary markets.